ORLANDO, FL / ACCESS Newswire / April 21, 2026 / RedChip Companies, an industry leader in investor relations, media, ...
We'll know more about the company's medium-term prospects by the end of the year.
Shares of several pharmaceutical companies were up after President Trump signed an executive order aimed at accelerating research, development access to psychedelic medicines for the treatment of ...
If biotech funding continues to increase this year, Danaher could benefit.
Legend Biotech ( LEGN +18.42%) was one of the healthier healthcare stocks on the market as the trading week kicked off on ...
On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...
The Chosun Ilbo on MSN
Global pharma shifts to Chinese biotech for cheaper, faster drugs
Global pharmaceutical and biotech companies are opening their wallets to secure Chinese new drug candidates. As China has ...
Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) fell 5.7% in the afternoon session after Jefferies ...
Introducing CPC Biotech - one brand uniting critical fluid management components New brand unites CPC’s Biopharma connector ...
After years of constrained capital markets, biotech companies are operating in an environment where even late-stage ...
Reputation Institute ranked drug companies from worst to best based on perception from the US. Overall, public trust and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results